Track Advaxis, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Advaxis, Inc. ADXS · Stock Open Advaxis, Inc. in new tab

0.6036 USD
Loading chart...

DCF valuation

Model fair value for Advaxis, Inc. (ADXS)
Result
Sign in to run the valuation for ADXS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Advaxis, Inc. Logo Advaxis, Inc. Analysis (ADXS)

United States Health Care Official Website Stock

Is Advaxis, Inc. a good investment? Advaxis, Inc. (ADXS) is currently trading at 0.6036 USD.

Investor FAQ

Does Advaxis, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Advaxis, Inc.?

Advaxis, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

Exchange Ticker
NMS (United States) ADXS
FRA (Germany) FAD2.F
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion